Total Funding
83
67
Total FundingVenture - Series Unknown raised
Growth Score
-8 pts
Heat Score
7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
30335
Ad Scientiam develop reliable solutions to measure disease evolution to accelerate treatment decisions to fight the disabilities.
Terence Brochu: CXO and UX Designer
Liouma Tokitsu: Co-Founder and CEO
About the Company
Ad Scientiam develops innovative digital solutions for patient monitoring in real life. Building on the growing possibilities offered by smartphones, Ad Scientiam creates new clinically-validated medical standards, in a collaborative ecosystem of patients, doctors and researchers.
MSCopilot® is Ad Scientiam’s first solution CE marked as a Class 1
medical device, dedicated to the monitoring of patients with multiple sclerosis. Ad Scientiam works on several other solutions in Alzheimer’s Disease, Parkinson's Disease, Rheumatoid Arthritis, etc.
Ad Scientiam employs 25 people at its two sites in France (the Pitié-Salpêtrière hospital and Station F campus) and in the United States (Seattle).
